ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
The effects of vitamin D2 or D3supplementation on glycaemic control and related metabolic parameters in people at risk of type 2 diabetes: protocol of a randomised double-blind placebo-controlled trial
BMC Public Health
◽
10.1186/1471-2458-13-999
◽
2013
◽
Vol 13
(1)
◽
Cited By ~ 3
Author(s):
Ravi K Menon
◽
Anna P Rickard
◽
Nasima Mannan
◽
Peter M Timms
◽
Stephen J Sharp
◽
...
Keyword(s):
Type 2 Diabetes
◽
At Risk
◽
Glycaemic Control
◽
Controlled Trial
◽
Metabolic Parameters
◽
Vitamin D2
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Related Documents
Cited By
References
Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double-blind placebo-controlled trial
Diabetes Obesity and Metabolism
◽
10.1111/dom.12625
◽
2016
◽
Vol 18
(4)
◽
pp. 392-400
◽
Cited By ~ 43
Author(s):
N. G. Forouhi
◽
R. K. Menon
◽
S. J. Sharp
◽
N. Mannan
◽
P. M. Timms
◽
...
Keyword(s):
Type 2 Diabetes
◽
At Risk
◽
Glycaemic Control
◽
Cardiometabolic Risk
◽
Controlled Trial
◽
Vitamin D2
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Faculty Opinions recommendation of Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.735542506.793559665
◽
2019
◽
Author(s):
Carmine Zoccali
◽
Davide Bolignano
Keyword(s):
Type 2 Diabetes
◽
Chronic Kidney Disease
◽
Kidney Disease
◽
Glycaemic Control
◽
Controlled Trial
◽
Double Blind
◽
Double Blind Placebo
◽
Lowering Effect
Download Full-text
The Effects of Choline and Magnesium Co-Supplementation on Metabolic Parameters, Inflammation, and Endothelial Dysfunction in Patients With Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled Trial
Journal of the American College of Nutrition
◽
10.1080/07315724.2019.1599745
◽
2019
◽
Vol 38
(8)
◽
pp. 714-721
◽
Cited By ~ 7
Author(s):
Samaneh Rashvand
◽
Majid Mobasseri
◽
Ali Tarighat-Esfanjani
Keyword(s):
Diabetes Mellitus
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Endothelial Dysfunction
◽
Controlled Trial
◽
Metabolic Parameters
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial
Diabetes Obesity and Metabolism
◽
10.1111/dom.12047
◽
2013
◽
Vol 15
(5)
◽
pp. 432-440
◽
Cited By ~ 90
Author(s):
K. Kaku
◽
S. Inoue
◽
O. Matsuoka
◽
A. Kiyosue
◽
H. Azuma
◽
...
Keyword(s):
Diabetes Mellitus
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Glycaemic Control
◽
Controlled Trial
◽
Japanese Patients
◽
Efficacy And Safety
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week, double-blind, placebo-controlled trial
Diabetes Obesity and Metabolism
◽
10.1111/j.1463-1326.2011.01434.x
◽
2011
◽
Vol 13
(10)
◽
pp. 928-938
◽
Cited By ~ 252
Author(s):
K. Strojek
◽
K. H. Yoon
◽
V. Hruba
◽
M. Elze
◽
A. M. Langkilde
◽
...
Keyword(s):
Type 2 Diabetes
◽
Glycaemic Control
◽
Controlled Trial
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial
The Lancet Diabetes & Endocrinology
◽
10.1016/s2213-8587(19)30086-5
◽
2019
◽
Vol 7
(6)
◽
pp. 429-441
◽
Cited By ~ 45
Author(s):
Carol Pollock
◽
Bergur Stefánsson
◽
Daniel Reyner
◽
Peter Rossing
◽
C David Sjöström
◽
...
Keyword(s):
Type 2 Diabetes
◽
Chronic Kidney Disease
◽
Kidney Disease
◽
Glycaemic Control
◽
Controlled Trial
◽
Double Blind
◽
Double Blind Placebo
◽
Lowering Effect
Download Full-text
Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trial
Diabetologia
◽
10.1007/s00125-017-4289-0
◽
2017
◽
Vol 60
(8)
◽
pp. 1390-1399
◽
Cited By ~ 29
Author(s):
Christoph Kapitza
◽
Kirsten Dahl
◽
Jacob B. Jacobsen
◽
Mads B. Axelsen
◽
Anne Flint
Keyword(s):
Type 2 Diabetes
◽
Glycaemic Control
◽
Beta Cell
◽
Beta Cell Function
◽
Cell Function
◽
Controlled Trial
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial
The Lancet
◽
10.1016/s0140-6736(10)60407-2
◽
2010
◽
Vol 375
(9733)
◽
pp. 2223-2233
◽
Cited By ~ 546
Author(s):
Clifford J Bailey
◽
Jorge L Gross
◽
Anne Pieters
◽
Arnaud Bastien
◽
James F List
Keyword(s):
Type 2 Diabetes
◽
Glycaemic Control
◽
Controlled Trial
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Using ginger supplement in adjunct with non-surgical periodontal therapy improves metabolic and periodontal parameters in patients with type 2 diabetes mellitus and chronic periodontitis: A double-blind, placebo-controlled trial
Journal of Herbal Medicine
◽
10.1016/j.hermed.2019.100315
◽
2020
◽
Vol 20
◽
pp. 100315
Author(s):
Hasan Gholinezhad
◽
Hadi Bazyar
◽
Homeira Rashidi
◽
Parvin Salehi
◽
Mohammad Hosein Haghighi-zadeh
◽
...
Keyword(s):
Diabetes Mellitus
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Chronic Periodontitis
◽
Controlled Trial
◽
Periodontal Therapy
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)
BMJ
◽
10.1136/bmj.328.7441.686-b
◽
2004
◽
Vol 328
(7441)
◽
pp. 686.3
Keyword(s):
Type 2 Diabetes
◽
Low Dose
◽
Controlled Trial
◽
Urinary Albumin
◽
Double Blind
◽
Double Blind Placebo
◽
Renal Outcomes
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close